添加微信 添加微信
添加微信
首页: 全球医药政策

新加坡-Novotech

时间:2021-10-21 14:03:24 来源:康安医药咨询 作者:康安医药咨询

Headquartered in Australia and focused exclusively on the Asia Pacific, Novotech is internationally recognized as a leading regional full-service CRO. With the increasing pace of globalization in drug development, Novotech’s expertise in the vibrant and fast growing Asian region has been instrumental in the success of hundreds of phase I-IV clinical trials from Australia to India. Headquartered in Sydney, with operations in New Zealand, China, Hong Kong, India, Malaysia, the Philippines, Singapore, South Korea, Taiwan and Thailand, Novotech’s service offering has come to be recognized for its quality both by our clients, as well as industry analyst groups.

Phone: 65, 6521, 37, 95 Fax: 65, 6521, 3801
Web: https://novotech-cro.com/
Add:302 Orchard Road #07-03,Tong Building, Singapore, 238862, Republic of Singapore

想要下载更多资料,请您添加微信了解详情!

微信号:csco2022

公众号:康安医药咨询

当前栏目

频道栏目

最新文章

热门文章